🔎 Trials Near Me

Gara Jalqabaatti › Luukemiya Limfoositiikii Keessummaa › Iowa › Des Moines

Qorannoo klinikaalii Luukemiya Limfoositiikii Keessummaa Des Moines, IA keessatti

Qorannoo 8 Luukemiya Limfoositiikii Keessummaa f Des Moines fi naannoo isaa (kilomeetira 30 keessatti) hirmaatuu jiru. Qorannoo banaa eenyu akka hirmaatu fi akkamitti garee qorannoo akka quunnaman ilaali.

Takkalaa qorannoo (Ingiliffa)

Qorannoo hirmaatuu barbaadduu? Fuula kana jalatti agarsiisi — $99 guyyaa 30f →

Testing the Addition of Anti-Cancer Drug Sonrotoclax, to the Standard Treatment Zanubrutinib, for Previously Untreated CLL/SLL

Namoota walitti qabaa jiraSadarkaa 3
  • Iowa Methodist Medical Center, Des Moines
  • UI Health Care Mission Cancer and Blood - Des Moines Clinic, Des Moines
  • Broadlawns Medical Center, Des Moines
  • fi 5 dabalataa
Umuriin 65 fi ol · Saalaa hunda · Haaromfame 02-Onk-2026 · NCT07321652

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

Namoota walitti qabaa jiraQorannoo ilaalaaHojjettoota fayyaa simatamoo
  • Iowa Methodist Medical Center, Des Moines
  • UI Health Care Mission Cancer and Blood - Des Moines Clinic, Des Moines
  • Mercy Medical Center - Des Moines, Des Moines
  • fi 6 dabalataa
Umuriin 40 hanga 75 · Saalaa hunda · Haaromfame 02-Onk-2026 · NCT05334069

Testing Early Treatment for Patients With High-Risk Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SLL), EVOLVE CLL/SLL Study

Namoota walitti qabaa jiraSadarkaa 3
  • Iowa Methodist Medical Center, Des Moines
  • UI Health Care Mission Cancer and Blood - Des Moines Clinic, Des Moines
  • Broadlawns Medical Center, Des Moines
  • fi 5 dabalataa
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 30-Ful-2026 · NCT04269902

A Study to Evaluate the Safety and Efficacy of Tacabrutideg (BGB-16673) Compared to Pirtobrutinib in Adults With Relapsed/Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

Namoota walitti qabaa jiraSadarkaa 3
  • Mission Cancer and Blood, Waukee · Miili 14 fagaatti
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 28-Ful-2026 · NCT06973187

A Study of Nemtabrutinib (MK-1026) Versus Comparator (Investigator's Choice of Ibrutinib or Acalabrutinib) in First Line (1L) Chronic Lymphocytic Leukemia (CLL)/ Small Lymphocytic Lymphoma (SLL) (MK-1026-011/BELLWAVE-011)

Namoota walitti qabaa jiraSadarkaa 3
  • University of Iowa Health Care. ( Site 0057), Waukee · Miili 14 fagaatti
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 24-Ful-2026 · NCT06136559

A Study Evaluating the Efficacy and Safety of Pirtobrutinib in Participants With Relapsed or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

Namoota walitti qabaa jiraSadarkaa 2
  • Mission Cancer + Blood, Waukee · Miili 14 fagaatti
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 19-Cam-2026 · NCT06588478

A Study to Evaluate the Risk of Tumor Lysis Syndrome (TLS) in Adult Participants Receiving Oral Venetoclax in Combination With Intravenously Infused Obinutuzumab or Oral Acalabrutinib for Previously Untreated Chronic Lymphocytic Leukemia (CLL)

Namoota walitti qabaa jiraSadarkaa 3
  • University of Iowa Health Care /ID# 267206, Des Moines
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 09-Elb-2026 · NCT06428019

Qorannoo Luukemiya Limfoositiikii Keessummaa magaalota biroo keessatti

Qorannoo biroo Des Moines keessatti

Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.